Astrazeneca (NYSE:AZN) Receives Buy Rating from Jefferies Financial Group
Astrazeneca (NYSE:AZN – Get Free Report)‘s stock had its “buy†rating reiterated by analysts at Jefferies Financial Group in a report issued on Wednesday,MarketScreener reports. AZN has been the subject of a number of other research reports. TD Cowen restated a “buy†rating on shares of Astrazeneca in a research note on Wednesday, March 18th. […]
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
